VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

T. Rowe Price Investment Management, Inc.'s Holding History (CIK: 0001897612)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 2,491,949 Value ($000) $11 Avg Close — Range —
Q4 2024
Shares 2,352,599 Value ($000) $13 Avg Close — Range —
Q3 2024
Shares 2,425,073 Value ($000) $12 Avg Close — Range —
Q2 2024
Shares 4,528,712 Value ($000) $22 Avg Close — Range —
Q1 2024
Shares 4,576,424 Value ($000) $61 Avg Close — Range —
Q4 2023
Shares 3,174,352 Value ($000) $44 Avg Close — Range —
Q3 2023
Shares 2,105,298 Value ($000) $28 Avg Close — Range —
Q2 2023
Shares 2,101,361 Value ($000) $39 Avg Close — Range —
Q1 2023
Shares 2,006,127 Value ($000) $29 Avg Close — Range —
Q4 2022
Shares 1,799,650 Value ($000) $35 Avg Close — Range —
Q3 2022
Shares 1,254,816 Value ($000) $43,103 Avg Close — Range —